CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | DALESANDRO MARGARET Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-01-05 | Ward Keith Wayne Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-01-05 | Rai Sukhwinder Singh Director | Grant or award · Stock Option (Right to Buy) | +250,000 | $0.02 | $4K | 250,000 |
| 2023-01-05 | TYLE PRAVEEN Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-11-10 | Emerald Health Sciences Inc. 10% owner | Other acquisition · Warrants | +9,141,486 | 9,141,486 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award | +1,406,543 | 4,406,543 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award | +2,335,721 | 2,335,721 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +487,500 | 487,500 | ||
| 2022-11-10 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +292,500 | 292,500 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award | +22,157 | 22,157 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award | +73,561 | 73,561 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award · Stock Option (Right to Buy) | +146,250 | 146,250 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award · Stock Option (Right to Buy) | +146,250 | 146,250 | ||
| 2022-11-10 | Rai Sukhwinder Singh Director | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2021-12-14 | DHILLON PUNIT Chief Executive Officer | Grant or award | +2,000,000 | 3,000,000 | ||
| 2021-12-14 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,090,000 | 3,090,000 | ||
| 2021-12-14 | Arsenault Kaitlyn Melanie Chief Financial Officer | Grant or award | +1,000,000 | 1,000,000 |
Page 11 of 15 · 292 trades